Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s patients, is thought to be the cause ofAlzheimer’s Disease (AD). AD is the most common neurodegenerativedisease and afflicts about 10% of the population over 60 4.